10.1136/esmoopen-2017-000299 - Sequential HER2 blockade as effective...

This document has been corrected

Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case

10.1136/esmoopen-2017-000299

Published Online: 2018-?-?

Journal: ESMO Open•Publisher: Elsevier BV

Authors: Alberto Bardelli•Andrea Sartore-Bianchi•AnnaMaria Rachiglio•Claudia Cardone•Davide Ciardiello•Erika Martinelli•Fortunato Ciardiello•Giulia Martini•Nicola Normanno•PietroPaolo Vitiello•Salvatore Siena•Silvia Marsoni•Teresa Troiani•Vincenzo Sforza

This document has been corrected

Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case

10.1136/esmoopen-2017-000299

Published Online: 2018-?-?

Journal: ESMO Open

NOW

2019-01-01•Erratum

Correction: Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case

10.1136/esmoopen-2017-000299corr1

* information provided by CrossRef

2019-01-01•Erratum

10.1136/esmoopen-2017-000299corr1

* information provided by CrossRef

2018-?-?•Published

2019-01-01•Erratum

Correction: Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case

10.1136/esmoopen-2017-000299corr1

* information provided by CrossRef

This document has been corrected

Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case

10.1136/esmoopen-2017-000299

Published Online: 2018-?-?

Journal: ESMO Open•Publisher: Elsevier BV